These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34724287)

  • 1. Effects of exergaming on hippocampal volume and brain-derived neurotrophic factor levels in Parkinson's disease.
    Schaeffer E; Roeben B; Granert O; Hanert A; Liepelt-Scarfone I; Leks E; Otterbein S; Saraykin P; Busch JH; Synofzik M; Stransky E; Bartsch T; Berg D
    Eur J Neurol; 2022 Feb; 29(2):441-449. PubMed ID: 34724287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of hippocampal subfields in the progression of cognitive decline related to Parkinson's disease.
    Foo H; Mak E; Chander RJ; Ng A; Au WL; Sitoh YY; Tan LC; Kandiah N
    Neuroimage Clin; 2017; 14():37-42. PubMed ID: 28116240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do multiple system atrophy and Parkinson's disease show distinct patterns of volumetric alterations across hippocampal subfields? An exploratory study.
    Wang N; Zhang L; Yang H; Luo X; Fan G
    Eur Radiol; 2019 Sep; 29(9):4948-4956. PubMed ID: 30796577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal subfield atrophy in patients with Parkinson's disease and psychosis.
    Lenka A; Ingalhalikar M; Shah A; Saini J; Arumugham SS; Hegde S; George L; Reddy V; Reddy YCJ; Yadav R; Pal PK
    J Neural Transm (Vienna); 2018 Sep; 125(9):1361-1372. PubMed ID: 29858658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of BDNF Val66Met polymorphism on hippocampal subfields in multiple sclerosis patients.
    De Meo E; Portaccio E; Prestipino E; Nacmias B; Bagnoli S; Razzolini L; Pastò L; Niccolai C; Goretti B; Bellinvia A; Fonderico M; Giorgio A; Stromillo ML; Filippi M; Sorbi S; De Stefano N; Amato MP
    Mol Psychiatry; 2022 Feb; 27(2):1010-1019. PubMed ID: 34650209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct hippocampal subfield atrophy in Parkinson's disease regarding motor subtypes.
    Luo C; Gao Y; Hu N; Wei X; Xiao Y; Wang W; Lui S; Gong Q
    Parkinsonism Relat Disord; 2021 Dec; 93():66-70. PubMed ID: 34808520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal volume changes of hippocampal subfields and cognitive decline in Parkinson's disease.
    Xu R; Hu X; Jiang X; Zhang Y; Wang J; Zeng X
    Quant Imaging Med Surg; 2020 Jan; 10(1):220-232. PubMed ID: 31956544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional vulnerability of hippocampal subfields and memory deficits in Parkinson's disease.
    Pereira JB; Junqué C; Bartrés-Faz D; Ramírez-Ruiz B; Marti MJ; Tolosa E
    Hippocampus; 2013 Aug; 23(8):720-8. PubMed ID: 23553678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between hippocampal structure and serum Brain-Derived Neurotrophic Factor (BDNF) in healthy adults: A registered report.
    Puhlmann LMC; Linz R; Valk SL; Vrticka P; Vos de Wael R; Bernasconi A; Bernasconi N; Caldairou B; Papassotiriou I; Chrousos GP; Bernhardt BC; Singer T; Engert V
    Neuroimage; 2021 Aug; 236():118011. PubMed ID: 33852941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal subfield atrophy of CA1 and subicular structures predict progression to dementia in idiopathic Parkinson's disease.
    Low A; Foo H; Yong TT; Tan LCS; Kandiah N
    J Neurol Neurosurg Psychiatry; 2019 Jun; 90(6):681-687. PubMed ID: 30683708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal volume is related to olfactory impairment in Parkinson's disease.
    Roh H; Kang J; Koh SB; Kim JH
    J Neuroimaging; 2021 Nov; 31(6):1176-1183. PubMed ID: 34355455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDNF Val66Met genotype interacts with childhood adversity and influences the formation of hippocampal subfields.
    Frodl T; Skokauskas N; Frey EM; Morris D; Gill M; Carballedo A
    Hum Brain Mapp; 2014 Dec; 35(12):5776-83. PubMed ID: 25044977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional hippocampal vulnerability in early multiple sclerosis: Dynamic pathological spreading from dentate gyrus to CA1.
    Planche V; Koubiyr I; Romero JE; Manjon JV; Coupé P; Deloire M; Dousset V; Brochet B; Ruet A; Tourdias T
    Hum Brain Mapp; 2018 Apr; 39(4):1814-1824. PubMed ID: 29331060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal CA1 subfield predicts episodic memory impairment in Parkinson's disease.
    La C; Linortner P; Bernstein JD; Ua Cruadhlaoich MAI; Fenesy M; Deutsch GK; Rutt BK; Tian L; Wagner AD; Zeineh M; Kerchner GA; Poston KL
    Neuroimage Clin; 2019; 23():101824. PubMed ID: 31054380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verbal memory is associated with structural hippocampal changes in newly diagnosed Parkinson's disease.
    Beyer MK; Bronnick KS; Hwang KS; Bergsland N; Tysnes OB; Larsen JP; Thompson PM; Somme JH; Apostolova LG
    J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):23-8. PubMed ID: 23154124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo analysis of hippocampal subfield atrophy in mild cognitive impairment via semi-automatic segmentation of T2-weighted MRI.
    Pluta J; Yushkevich P; Das S; Wolk D
    J Alzheimers Dis; 2012; 31(1):85-99. PubMed ID: 22504319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volumetric and shape analysis of hippocampal subfields in unilateral mesial temporal lobe epilepsy with hippocampal atrophy.
    Kim JB; Suh SI; Kim JH
    Epilepsy Res; 2015 Nov; 117():74-81. PubMed ID: 26425829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of volume alterations in hippocampal subfields of rats under chronic unpredictable mild stress using 7T MRI: A follow-up study.
    Li Y; Zhu X; Ju S; Yan J; Wang D; Zhu Y; Zang F
    J Magn Reson Imaging; 2017 Nov; 46(5):1456-1463. PubMed ID: 28225578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease is associated with hippocampal atrophy.
    Camicioli R; Moore MM; Kinney A; Corbridge E; Glassberg K; Kaye JA
    Mov Disord; 2003 Jul; 18(7):784-90. PubMed ID: 12815657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent exergaming and transcranial direct current stimulation to improve balance in people with Parkinson's disease: study protocol for a randomised controlled trial.
    Harris DM; Rantalainen T; Muthalib M; Johnson L; Duckham RL; Smith ST; Daly RM; Teo WP
    Trials; 2018 Jul; 19(1):387. PubMed ID: 30012175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.